Patent_application_number,Applicant_name,Year_of_application,Patent_system
EP2402445A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2402448A2,DU PONT,2012,EPO
EP2403939A1,UNIV NANYANG TECH [SG],2012,EPO
EP2404994A1,OTSUKA PHARMACEUTICAL,2012,EPO
EP2404995A1,OTSUKA PHARMACEUTICAL,2012,EPO
EP2405003A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2405004A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2405007A1,DU PONT,2012,EPO
EP2405012A1,DU PONT,2012,EPO
EP2405014A1,IFF,2012,EPO
EP2407488A2,PROCELL THERAPEUTICS INC [KR]; JO DAEWOONG [KR],2012,EPO
EP2407542A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2408795A1,DSM IP ASSETS BV,2012,EPO
EP2408797A2,DSM IP ASSETS BV,2012,EPO
EP2408922A1,DSM IP ASSETS BV,2012,EPO
EP2410061A1,SCHWARZ WOLFGANG,2012,EPO
EP2420253A1,LEADARTIS S L [ES],2012,EPO
EP2438173A2,UNIV OHIO STATE RES FOUND [US],2012,EPO
EP2439271A1,TORAY,2012,EPO
EP2440033A2,EVOGENE,2012,EPO
EP2441828A1,STAZIONE ZOOL ANTON DOHRN [IT],2012,EPO
EP2441832A1,JAPAN TOBACCO INC,2012,EPO
EP2441842A1,DU PONT,2012,EPO
EP2441843A1,DU PONT,2012,EPO
EP2450434A2,BASF,2012,EPO
EP2456875A1,GOVERNMENT OF CHINA,2012,EPO
EP2478008A2,"GRUBER DAVID [US], KAO HUNG-TEH [US], PIERIBONE VINCENT [US]",2012,EPO
EP2479272A1,AJINOMOTO,2012,EPO
EP2480680A1,CHEVRON,2012,EPO
EP2489729A2,UNIV LOMA LINDA [US],2012,EPO
EP2496696A1,AGENCY FOR SCIENCE TECHNOLOGY AMD RESEARCH,2012,EPO
EP2508610A1,BASF,2012,EPO
EP2519097A2,EVOGENE,2012,EPO
EP2519636A1,DSM IP ASSETS BV,2012,EPO
EP2522216A1,DU PONT,2012,EPO
JP2012029679A,ASAHI,2012,JPO
JP2012031066A,HOKKAIDO UNIVERSITY,2012,JPO
JP2012034690A,TORAY,2012,JPO
JP2012062294A,AIST,2012,JPO
JP2012090630A,TAKEDA CHEMICAL INDUSTRIES LTD,2012,JPO
JP2012100537A,AJINOMOTO,2012,JPO
JP2012110275A,SANYO CHEMICAL INDUSTRIES LTD,2012,JPO
JP2012110330A,NIHON UNIVERSITY,2012,JPO
JP2012110336A,PRECIGEN,2012,JPO
JP2012110347A,NOVOZYMES,2012,JPO
JP2012120471A,EZAKI GLICO,2012,JPO
JP2012120507A,SEKISUI CHEMICAL,2012,JPO
JP2012125190A,KAKE EDUCATIONAL INSTITUTION,2012,JPO
JP2012125229A,ISHIKAWA PREFECTURE,2012,JPO
JP2012130332A,"NIHON SHOKUHIN KAKO CO LTD,HOKKAIDO UNIVERSITY",2012,JPO
JP2012147712A,THERMOSTABLE ENZYME LABORATORY,2012,JPO
JP2012183068A,YALE UNIVERSITY,2012,JPO
JP2012183071A,TAKARA HOLDINGS,2012,JPO
JP2012187057A,NAGASAKI PREFECTURE,2012,JPO
JP2012187112A,EXPRESSTEC,2012,JPO
JP2012187116A,THOMAS JEFFERSON UNIVERSITY (US),2012,JPO
JP2012191951A,NOVOZYMES,2012,JPO
JP2012196144A,AJINOMOTO,2012,JPO
JP2012205595A,CELANESE CORPORATION,2012,JPO
JP2012210208A,HOKKAIDO UNIVERSITY,2012,JPO
JP2012211912A,AIST,2012,JPO
JP2012213382A,NATIONAL UNIVERSITY OF CORPORATION HIROSHIMA UNIVERSITY,2012,JPO
JP2012213404A,HOLOGIC INC,2012,JPO
JP2012217357A,CHISSO CORPORATION,2012,JPO
JP2012217376A,CHISSO CORPORATION,2012,JPO
JP2012235773A,FISHERIES RESEARCH AGENCY,2012,JPO
JP2012249619A,AIST,2012,JPO
JP2012254073A,SCRIPPS RESEARCH INSTITUTE,2012,JPO
JP2012500640A,BASF,2012,JPO
JP2012501645A,KIOST,2012,JPO
JP2012502073A,NOVARTIS,2012,JPO
JP2012503992A,IFF,2012,JPO
JP2012503993A,IFF,2012,JPO
JP2012504418A,DU PONT,2012,JPO
JP2012504419A,DU PONT,2012,JPO
JP2012504420A,DU PONT,2012,JPO
JP2012504421A,DU PONT,2012,JPO
JP2012504422A,DU PONT,2012,JPO
JP2012504692A,DU PONT,2012,JPO
JP2012504938A,DU PONT,2012,JPO
JP2012504960A,ABBOTT LABORATORIES,2012,JPO
JP2012504963A,CHEVRON,2012,JPO
JP2012506714A,"BERNT TH WALTHER,MIRUSHE H MIFTARI",2012,JPO
JP2012507986A,ROCHE,2012,JPO
JP2012509059A,CSIRO,2012,JPO
JP2012510262A,TOTAL,2012,JPO
JP2012510263A,TOTAL,2012,JPO
JP2012511908A,BIO ARCHITECTURE LAB,2012,JPO
JP2012511913A,REGENERON PHARMA,2012,JPO
JP2012514453A,UKHSA,2012,JPO
JP2012514986A,KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE,2012,JPO
JP2012515729A,NSGENE A/S,2012,JPO
JP2012520070A,DSM IP ASSETS BV,2012,JPO
JP2012520676A,DSM IP ASSETS BV,2012,JPO
JP2012521195A,DSM IP ASSETS BV,2012,JPO
JP2012521753A,DU PONT,2012,JPO
JP2012521755A,KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION,2012,JPO
JP2012525819A,PROMEGA CORPORATION,2012,JPO
JP2012527223A,ETH ZURICH,2012,JPO
JP2012528572A,HALO-BIO RNAI THERAPEUTICS INC,2012,JPO